Assessing Asthma Control to Improve Patient Outcomes

Title:

Assessing Asthma Control to Improve Patient Outcomes

Topic: Pulmonary Disease
Relevant Terms: Pediatrics, Primary Care
Primary Audience: This activity has been designed for primary care physicians; pediatricians; allied health professionals; and other healthcare providers involved in the care of patients with asthma.
Launch Date: 05-Sep-13
Credits: AMA PRA Category 1 Credit
Expiration Date: 04-Sep-14

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Describe clinical characteristics of patients who may be at risk for asthma exacerbations
  2. Implement guideline-based strategies in clinical decision making for the treatment of patients with asthma
  3. Develop treatment plans that target underlying inflammation throughout the respiratory tract
  4. Utilize patient education and routine monitoring to ensure prescribed treatment is effective

    Faculty

     Richard J. Martin, MD
     Chairman
     Department of Medicine
     National Jewish Health
     The Edelstein Chair in Pulmonary Medicine
     Professor of Medicine
     National Jewish Health and the University of Colorado Denver
     Denver, Colorado
    Accreditation Statement
     
    National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
     
    Credit Designation
     
    National Jewish Health designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
     
    Disclosure of Conflicts of Interest
     
    All faculty in a position to control the content of this activity are expected to disclose any or no significant financial interest or other relationship with any proprietary entity producing health care goods or services, with the exemption of non-profit or governmental organizations and non-health care related companies. Our goal is to ensure that there is no compromise of the ethical relationship that exists between those in a position to control the content of the activity and those attending the activity and their respective professional duties.
     
    Significant financial interest is defined as receiving, or in the past twelve months having received, a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (eg, stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.
     
    For the purposes of CME accreditation National Jewish Health considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
     
    All CME Educational Activities sponsored by National Jewish Health are reviewed to ensure a balanced and evidence-based presentation by our faculty CME committee. Any potential conflict of interest among program faculty has been identified and resolved according to ACCME guidelines.
     
    Sean Gregory, PhD
    Has no significant financial interest to report.
     
    Richard J. Martin, MD
    Consultant: Merck, Teva
    Investigator: MedImmune
     
    Harold Nelson, MD
    Consultant: Merck, Pearl, Shionogi
    Investigator: Circassia, Lincoln Diagnostics, Rigel

    Activity Length
    The estimated time required to complete this activity is 1.0 hour.
     
    National Jewish Health
     
    For questions about the accreditation of this activity, please contact National Jewish Health at 1-800-844-2305 or visit www.nationaljewish.org/CME.

    Disclosure of Unlabeled Use
     
    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. National Jewish Health, Integrity Continuing Education, Inc., and TEVA Respiratory do not recommend the use of any agent outside of the labeled indications.
     
    The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of National Jewish Health, Integrity Continuing Education, Inc., and TEVA Respiratory. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
     
    Disclaimer
     
    The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.
     
    COURSE VIEWING REQUIREMENTS
    Supported Browsers:
    Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
    Google Chrome 18.0+ for Windows, Mac OS, or Linux
    Mozilla Firefox 13.0+ for Windows, Mac OS, or Linux
    Safari 4.0+ for Mac OSX 10.5 and above
    Supported Phones & Tablets:
    Android 4.0.3 and above
    iPhone/iPad with iOS 6.1 or above